Caris Life Sciences, Inc. Common Stock (CAI) is a publicly traded Healthcare sector company. As of May 20, 2026, CAI trades at $15.85 with a market cap of $4.27B and a P/E ratio of -2.47. CAI moved +4.88% today. Year to date, CAI is -40.55%; over the trailing twelve months it is flat. Its 52-week range spans $14.19 to $42.50. Analyst consensus is strong buy with an average price target of $27.92. Rallies surfaces CAI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Caris Life Sciences, Inc. Common Stock (CAI) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. CAI moved +4.88% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $15.85 |
| Market Cap | $4.27B |
| P/E Ratio | -2.47 |
| EPS | $-6.27 |
| Dividend Yield | 0.30% |
| 52-Week High | $42.50 |
| 52-Week Low | $14.19 |
| Volume | 2.50M |
| Avg Volume | 0 |
| Revenue (TTM) | $907.29M |
| Net Income | $33.98M |
| Gross Margin | 0.00% |
12 analysts cover CAI: 0 strong buy, 10 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $27.92.